WLan HoldingFairJourney BiologicsNew CEO strengthens managementFairJourney Biologics (Porto, PT) has appointed Dr Werner Lanthaler, long-standing Evotec CEO, as Chief Executive Officer. Founder António Parada will focus on innovation strategy on the Supervisory … more ➔
Julius ClinicalJulius ClinicalNew CEO takes overContract Research Organization Julius Clinical (NL) appointed Bassem Saleh as its new Chief Executive Officer. His predecessor, Martijn Wallert, will become an advisor to the Executive Board. more ➔
Tesselate BioTesselate BioNew Chief Scientific Officer has startedTessellate Bio (Naarden, Netherlands; Stevenage, UK) appointed Dr Katie Chapman as Chief Scientific Officer (CSO) at the end of September. She succeeds Dr Jürgen Moll, who will be available to the … more ➔
AlzeCure Pharma ABAlzecure PharmaNew Head of DevelopmentSwedish AlzeCure Pharma AB recently appointed Cecilia Wadell as Head of Development. She joins also the management team. more ➔
FotografEnzymatica ABSuccessor found for CEOSana Alajmovic has been appointed as the new CEO of the Swedish company Enzymatica AB by the Board of Directors. The current CEO, Claus Egstrand, will become a member of the Board. more ➔
Centauri TherapeuticsCentauri TherapeuticsExperienced immunologist as CMOImmunotherapy company Centauri Therapeutics Ltd, based in Alderley Park, Cheshire, UK, has announced the appointment of Dr Debra Barker as Chief Medical Officer (CMO). more ➔
ArcinovaArcinovaNew managing director takes overUK-based contract research, development and manufacturing organisation (CRDMO) Arcinova announced the appointment of Dr Christian Dowdeswell as its new managing director at the beginning of August. Co-founder … more ➔
Enzymatica ABEnzymatica ABEnzymatica CEO steps downThe CEO of Lund-based Enzymatica AB, Claus Egstrand, is stepping down from his role. CFO Therese Filmersson will also leave her position. The process of finding their successors has already begun. more ➔
MC2 Therapeutics A/SMC2 Therapeutics A/SNew CEO – new chapterMC2 Therapeutics A/S, a Hørsholm-based pharmaceutical company focused on topical therapies in inflammatory skin conditions, announced the appointment of Trine Ahlgreen as Chief Executive Officer at … more ➔
Sibylla BiotechSibylla BiotechIndustry veteran appointedItalian Sibylla Biotech has appointed a new Chairman of the Board of Directors: Dieter Weinand, former President, CEO and Chairman of the Board of Bayer Pharmaceuticals AG. more ➔
WLan Holding
Julius Clinical
Tesselate Bio
AlzeCure Pharma AB
Fotograf
Centauri Therapeutics
Arcinova
Enzymatica AB
MC2 Therapeutics A/S
Sibylla Biotech